Literature DB >> 19667217

Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.

Emmanuelle Waubant1, Dorothee Chabas, Darin T Okuda, Orit Glenn, Ellen Mowry, Roland G Henry, Jonathan B Strober, Bruno Soares, Max Wintermark, Daniel Pelletier.   

Abstract

OBJECTIVE: To compare initial brain magnetic resonance imaging (MRI) characteristics of children and adults at multiple sclerosis (MS) onset.
DESIGN: Retrospective analysis of features of first brain MRI available at MS onset in patients with pediatric-onset and adult-onset MS.
SETTING: A pediatric and an adult MS center. PATIENTS: Patients with pediatric-onset <18 years) and adult-onset (> or =18 years) MS. MAIN OUTCOME MEASURES: We evaluated initial and second (when available) brain MRI scans obtained at the time of first MS symptoms for lesions that were T2-bright, ovoid and well defined, large (> or =1cm), or enhancing.
RESULTS: We identified 41 patients with pediatric-onset MS and 35 patients with adult-onset MS. Children had a higher number of total T2- (median, 21 vs 6; P < .001) and large T2-bright areas (median, 4 vs 0; P < .001) than adults. Children more frequently had T2-bright foci in the posterior fossa (68.3% vs 31.4%; P = .001) and enhancing lesions (68.4% vs 21.2%; P < .001) than adults. On the second brain MRI, children had more new T2-bright (median, 2.5 vs 0; P < .001) and gadolinium-enhancing foci (P < .001) than adults. Except for corpus callosum involvement, race/ethnicity was not strongly associated with disease burden or lesion location on the first scan, although other associations cannot be excluded because of the width of the confidence intervals.
CONCLUSION: While it is unknown whether the higher disease burden, posterior fossa involvement, and rate of new lesions in pediatric-onset MS are explained by age alone, these characteristics have been associated with worse disability progression in adults.

Entities:  

Mesh:

Year:  2009        PMID: 19667217     DOI: 10.1001/archneurol.2009.135

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  38 in total

1.  Magnetic resonance imaging features of the spinal cord in pediatric multiple sclerosis: a preliminary study.

Authors:  Leonard H Verhey; Helen M Branson; Monica Makhija; Manohar Shroff; Brenda Banwell
Journal:  Neuroradiology       Date:  2010-08-19       Impact factor: 2.804

2.  Efficacy of fingolimod after switching from interferon β-1a in an adolescent with multiple sclerosis: case report.

Authors:  Annalisa Amidei; Gabriele Siciliano; Livia Pasquali
Journal:  Neurol Sci       Date:  2021-03-16       Impact factor: 3.307

3.  Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more.

Authors:  Marie Cathrin Mayer; Edgar Meinl
Journal:  Ther Adv Neurol Disord       Date:  2012-05       Impact factor: 6.570

4.  [Diagnosis of multiple sclerosis 2010 revision of the McDonald criteria].

Authors:  L Klotz; R Gold; B Hemmer; T Korn; F Zipp; R Hohlfeld; B C Kieseier; H Wiendl
Journal:  Nervenarzt       Date:  2011-10       Impact factor: 1.214

Review 5.  Therapies for multiple sclerosis: considerations in the pediatric patient.

Authors:  Brenda Banwell; Amit Bar-Or; Gavin Giovannoni; Russell C Dale; Marc Tardieu
Journal:  Nat Rev Neurol       Date:  2011-01-11       Impact factor: 42.937

6.  Therapeutic strategies in childhood multiple sclerosis.

Authors:  Angelo Ghezzi
Journal:  Ther Adv Neurol Disord       Date:  2010-07       Impact factor: 6.570

7.  The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps.

Authors:  T Charles Casper; John W Rose; Shelly Roalstad; Emmanuelle Waubant; Gregory Aaen; Anita Belman; Tanuja Chitnis; Mark Gorman; Lauren Krupp; Timothy E Lotze; Jayne Ness; Marc Patterson; Moses Rodriguez; Bianca Weinstock-Guttman; Brittan Browning; Jennifer Graves; Jan-Mendelt Tillema; Leslie Benson; Yolanda Harris
Journal:  J Child Neurol       Date:  2014-09-30       Impact factor: 1.987

8.  Tract-based spatial statistics analysis of diffusion-tensor imaging data in pediatric- and adult-onset multiple sclerosis.

Authors:  Rachel Aliotta; Jennifer L Cox; Katelyn Donohue; Bianca Weinstock-Guttman; E Ann Yeh; Paul Polak; Michael G Dwyer; Robert Zivadinov
Journal:  Hum Brain Mapp       Date:  2012-08-30       Impact factor: 5.038

Review 9.  Disease-modifying therapy of pediatric multiple sclerosis.

Authors:  Tanuja Chitnis
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

10.  No evidence of disease activity including cognition (NEDA-3 plus) in naïve pediatric multiple sclerosis patients treated with natalizumab.

Authors:  Monica Margoni; Francesca Rinaldi; Alice Riccardi; Silvia Franciotta; Paola Perini; Paolo Gallo
Journal:  J Neurol       Date:  2019-09-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.